FERNANDO GUILLEN: Open Payments
NPI 1861974024 · ANTHONY, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 30 payments from 7 companies in 2025. Trend: 2023 $1,501 · 2024 $884 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $170 |
| Alkermes, Inc. | 12 | $169 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| ABBVIE INC. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: REXULTI, LYBALVI, ARISTADA, ABILIFY MAINTENA, INGREZZA, COBENFY, INVEGA SUSTENNA, VRAYLAR.
Industry payments across NM — which companies pay providers there.
